DocMorris AG (CH:DOCM)
:DOCM
DOCM Stock Chart & Stats
CHF4.33
CHF0.36(1.86%)
At close: 4:00 PM EST
CHF4.33
CHF0.36(1.86%)
Day’s Range― - ―
52-Week RangeCHF3.92 - CHF12.26
Previous CloseN/A
Volume45.75K
Average Volume (3M)342.18K
Market Cap
CHF203.36M
Enterprise ValueCHF308.18M
Total Cash (Recent Filing)CHF159.50M
Total Debt (Recent Filing)CHF262.20M
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding51,617,825
10 Day Avg. Volume377,518
30 Day Avg. Volume342,178
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.75
Price to Sales (P/S)0.27
P/FCF Ratio-3.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF7.16Price Target Upside65.36% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)-1.61
Revenue Forecast (FY)CHF1.23B
Bulls Say, Bears Say
Bulls Say
Competitive Position ImprovementImproved performance versus a key peer indicates potential market share gains as the company gains traction while the peer slows.
Marketing-driven Growth AccelerationFocused marketing efforts combined with an especially strong flu season helped accelerate revenue growth after the company's balance sheet recapitalisation.
OTC Sales ReboundStrong over-the-counter demand in Germany supports top-line recovery as non-prescription volumes improve following targeted promotions.
Bears Say
Prescription Sales ShortfallPrescription revenue continues to lag analyst expectations, constraining revenue diversification and slowing overall sales momentum.
Profitability PressureOperating profitability remains under pressure with expectations of continued negative results, limiting upside for the stock until margins improve.
Reliance On External FundingMajor external capital injections point to ongoing dependence on outside financing, raising dilution and refinancing risk for shareholders.
DocMorris News
DOCM FAQ
What was DocMorris AG’s price range in the past 12 months?
DocMorris AG lowest stock price was CHF3.92 and its highest was CHF12.26 in the past 12 months.
What is DocMorris AG’s market cap?
DocMorris AG’s market cap is CHF203.36M.
When is DocMorris AG’s upcoming earnings report date?
DocMorris AG’s upcoming earnings report date is Aug 19, 2026 which is in 145 days.
How were DocMorris AG’s earnings last quarter?
Currently, no data Available
Is DocMorris AG overvalued?
According to Wall Street analysts DocMorris AG’s price is currently Undervalued.
Does DocMorris AG pay dividends?
DocMorris AG does not currently pay dividends.
What is DocMorris AG’s EPS estimate?
DocMorris AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DocMorris AG have?
DocMorris AG has 51,617,825 shares outstanding.
What happened to DocMorris AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of DocMorris AG?
Currently, no hedge funds are holding shares in CH:DOCM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DocMorris AG
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
DOCM Stock 12 Month Forecast
Average Price Target
CHF7.16
▲(65.36% Upside)
Technical Analysis
Idorsia Ltd
―
Santhera Pharmaceuticals Holding
―
Galenica AG
―
Galderma Group AG
―
medmix AG
―
Options Prices
Currently, No data available
---